Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds
Socio-Economic Factors, Access To Care, Associated With More Aggressive Cancers
Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds
GSK HPV Vaccine Offers Protection From 4 HPV Types
Aspirin Use Associated With Lower Cancer Indicence, Death
Early ADT Doesn’t Offer Survival Advantage—ASCO
Gleevec Decreases Recurrence Of Gastrointestinal Tumor
NCI-Approved Cancer Center, Cooperative Group Trials
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









